Halda Therapeutics

Halda Therapeutics

Private
New Haven, ConnecticutHealthcare & Life Scienceshaldatx.com

Last Round

Series B

Extension

Aug 12, 2024

Total Funding Raised

$202M

Momentum Score

25 /100

Company Overview

Halda Therapeutics is a biotechnology company that specializes in developing a drug discovery platform aimed at creating therapeutic and precision medicines by targeting disease-causing pathways with innovative therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

RIPTACsRIPTAC platforminduced proximitysmall molecule therapiescancer drug resistancenext-gen cancer drugs"hold and kill" mechanismheterobifunctional moleculesprostate cancer therapymetastatic castration-resistant prostate cancermCRPCsolid tumor therapyPROTAC alternativesprecision oncologyregulated induced proximity targeting chimerasbreast cancer therapyclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Halda Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Halda Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionAug 12, 2024
Series BDec 9, 2021
Series AFeb 1, 2019

Key People

Founding team and executive leadership

Chris Schade

Chief Executive Officer

Executive Team

Scott Phillips

Chief Financial Officer

Executive Team

Halda Therapeutics Investors

Notable investors and investment history

InvestorRounds
Access IndustriesSeries B Extension
Connecticut InnovationsSeries B, Series A, Series B Extension
RA Capital ManagementSeries B Extension
Boxer CapitalSeries B Extension
Taiho VenturesSeries B Extension
Vida VenturesSeries B Extension
Deep Track CapitalSeries B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Now operating as a Johnson & Johnson company.

  • Oct 24, 2025

    Presenting clinical data for HLD-0915 at AACR-NCI-EORTC conference.

Halda Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Halda Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Halda Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Haven, Connecticut
Employee Range43
Year Founded2019
Last FundingAug 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.